Dickens opened "A Tale of Two Cities" with the observation that his era was simultaneously the best and worst of times.

IonQ moves ahead of QBTS and RGTI in 2026 with higher gate fidelity, faster execution and stronger revenue momentum, though ...

Krystal Biotech is upgraded to Strong Buy as Vyjuvek sales surge and catalysts build. Click here to know more.

EADaily, . Multi-vector no longer works. The war has reached Kazakhstan, no matter how much it shuns it. The telegram channel "Baraeva" writes about this.

Weighing innovation, reputation, business value, cost, integration overhead, and peer use, among other criteria, CISOs list ...

Ocugen, Inc. gene therapy outlook: key 2026 catalysts, Phase 2/3 eye-disease data, BLA plans to 2028, and risks. Click for ...

The pro-Kremlin TV commentator Vladimir Solovyov’s latest remarks framing Central Asia as Russia’s “sphere of interest” and calling the region “our Asia” sparked a strong public response.

Degree Pharmaceuticals, Inc. NASDAQ: SXTP; SXTPW) ("60 Degrees Pharma" or the "Company"), a pharmaceutical company focused on developing new medicines ...

The journalist-turned-minister says the tech will make us richer and regulation should be “light” The post Evan Solomon Wants ...

Apple has announced a multi-year partnership with Google to power Siri using Gemini AI, launching with iOS 26.4 in March or ...

OpenAI CEO Sam Altman has had an unfortunate dose of reality, reckoning with the fact ChatGPT is a uniquely powerful money ...

The Tokyo summit marks not bloc-building in Eurasia, but Central Asia’s deliberate move to deepen its strategic autonomy ...